Use of Bromelain for Mild Ulcerative Colitis
Authors: Sunanda Kane, Michael J. Goldberg
Journal: Annals of Internal Medicine (2000)

Letters18 April 2000Use of Bromelain for Mild Ulcerative ColitisSunanda Kane, MD, MSPH and Michael J. Goldberg, MDSunanda Kane, MD, MSPHUniversity of Chicago Hospitals; Chicago, IL 60637 (Kane)University of Chicago Hospitals; Chicago, IL 60637 (Goldberg) and Michael J. Goldberg, MDUniversity of Chicago Hospitals; Chicago, IL 60637 (Kane)University of Chicago Hospitals; Chicago, IL 60637 (Goldberg)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-132-8-200004180-00026 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Ulcerative colitis is a chronic condition characterized by inflammation of the mucosal layer of the colon. Despite multiple treatments, some patients continue to be symptomatic and seek alternative therapy. We describe two patients who achieved clinical and endoscopic remission after initiation of bromelain supplementation.A 67-year-old woman with a history of ulcerative proctitis continued to have three to four bloody bowel movements per day despite adequate doses of sulfasalazine, mesalamine, and topical steroids. She discovered bromelain at a nutrition/herbal store after researching "digestive aids" and anti-inflammatory drugs. Within a week of taking two tablets of bromelain at ...References1. Smyth RD, Moss JN, Brennan R, Harris JC, Martin GJ. Biochemical studies on the resolution of experimental inflammations in animals treated with bromelain. Exp Med Surg. 1967;25:229-35. MedlineGoogle Scholar2. Lotti T, Mirone V, Imbimbo C, Corrado F, Corrado G, Garofalo F, et al . Controlled clinical studies of nimesulide in the treatment of urogenital inflammation. Drugs. 1993;46 Suppl 1 144-6. CrossrefMedlineGoogle Scholar3. Chandler DS, Mynott TL. Bromelain protects piglets from diarrhea caused by oral challenge with K88 positive enterotoxigenic Escherichia coli . Gut. 1998;43:196-202. CrossrefMedlineGoogle Scholar4. Folwaczny C, Wiebecke B, Loeschke K. Unfractionated heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol. 1999;94:1551-5. CrossrefMedlineGoogle Scholar5. Evans RC, Wong VS, Morris AI, Rhodes JM. Treatment of corticosteroid dependent ulcerative colitis with heparin—a report of 16 cases. Aliment Pharmacol Ther. 1997;11:1037-40. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: University of Chicago Hospitals; Chicago, IL 60637 (Kane)University of Chicago Hospitals; Chicago, IL 60637 (Goldberg) PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byBromelain, a Group of Pineapple Proteolytic Complex Enzymes (Ananas comosus) and Their Possible Therapeutic and Clinical Effects. A SummaryA Review of Four Practice Guidelines of Inflammatory Bowel DiseaseBromelain a Potential Bioactive Compound: A Comprehensive Overview from a Pharmacological PerspectiveNatural product–derived drugs for the treatment of inflammatory bowel diseases (IBD)A phytopharmacological overview of medicinal plants used for prophylactic and treatment of colitisTrends and Prospects of Plant Proteases in TherapeuticsBromelain effectively suppresses Kras-mutant colorectal cancer by stimulating ferroptosisInflammatory Bowel DiseaseEffects of Ananas comosus leaf powder on broiler performance, haematology, biochemistry, and gut microbial populationInhibition of Epithelial TNF-α Receptors by Purified Fruit Bromelain Ameliorates Intestinal Inflammation and Barrier Dysfunction in ColitisComplementary and Alternative TherapiesPotential role of bromelain in clinical and therapeutic applicationsBromelainCase Study: Recombinant Bromelain SelectionAlternative Medicines as Emerging Therapies for Inflammatory Bowel DiseasesInhibitory effects of bromelain, a cysteine protease derived from pineapple stem (Ananas comosus), on intestinal motility in miceDietary supplementation with fresh pineapple juice decreases inflammation and colonic neoplasia in IL-10-deficient mice with colitisPostdates pregnancy and complementary therapiesBromelain treatment decreases neutrophil migration to sites of inflammationBromelain treatment decreases secretion of pro-inflammatory cytokines and chemokines by colon biopsies in vitroRole of bromelain in the treatment of patients with pityriasis lichenoides chronicaBromelainBromelain improves decrease in defecation in postoperative rats: Modulation of colonic gene expression of inducible nitric oxide synthaseComplementary and alternative medicine in inflammatory bowel disease: keeping an open mindProteinase activity and stability of natural bromelain preparationsProteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of miceBromelain Treatment Alters Leukocyte Expression of Cell Surface Molecules Involved in Cellular Adhesion and ActivationBromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adultsNovel therapies in the treatment of ulcerative colitis 18 April 2000Volume 132, Issue 8Page: 680KeywordsArthralgiaEndoscopyEscherichia coli infectionsInflammationPatientsPlatelet aggregationProctitisSmall intestineSteroidsUlcerative colitis Issue Published: 18 April 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...